Depreciation of BIOLIFE SOLUTIONS INC from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
BIOLIFE SOLUTIONS INC quarterly and annual Depreciation in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • BIOLIFE SOLUTIONS INC Depreciation for the quarter ending 31 Dec 2025 was $200,000.
  • BIOLIFE SOLUTIONS INC Depreciation for the twelve months ending 31 Dec 2025 was $800,000, a 33% increase year-over-year.
  • BIOLIFE SOLUTIONS INC annual Depreciation for 2025 was $800,000, a 33% increase from 2024.
  • BIOLIFE SOLUTIONS INC annual Depreciation for 2024 was $600,000, a 14% decline from 2023.
  • BIOLIFE SOLUTIONS INC annual Depreciation for 2023 was $700,000, a 12% decline from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

BIOLIFE SOLUTIONS INC Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $800,000 $200,000 +$200,000 01 Oct 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $600,000 $200,000 $0 0% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $600,000 $200,000 $0 0% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $600,000 $200,000 $0 0% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $600,000 $0 +$2,000,000 01 Oct 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $1,400,000 $200,000 -$800,000 -80% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $600,000 $200,000 -$600,000 -75% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $0 $200,000 -$700,000 -78% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $700,000 $2,000,000 -$443,000 -28% 01 Oct 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
Q3 2023 $1,143,000 $1,000,000 +$100,000 +11% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $1,043,000 $800,000 +$100,000 +14% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024 2024 Q2
Q1 2023 $943,000 $900,000 +$143,000 +19% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q4 2022 $800,000 $1,557,000 -$2,372,000 -291% 01 Oct 2022 31 Dec 2022 10-K 03 Mar 2025 2024 FY
Q3 2022 $3,172,000 $900,000 +$209,000 +30% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $2,963,000 $700,000 -$119,000 -15% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 $3,082,000 $757,000 +$182,000 +32% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $2,900,000 $815,000 +$288,000 +55% 01 Oct 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
Q3 2021 $2,612,000 $691,000 +$395,000 +133% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 $2,217,000 $819,000 +$527,000 +180% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 $1,690,000 $575,000 +$290,000 +102% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $1,400,000 $527,000 +$305,000 +137% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2023 2022 FY
Q3 2020 $1,095,000 $296,000 +$182,000 +160% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 $913,000 $292,000 +$182,000 +165% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021 2021 Q2
Q1 2020 $731,000 $285,000 +$187,000 +191% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q4 2019 $544,000 $222,000 01 Oct 2019 31 Dec 2019 10-K 31 Mar 2022 2021 FY
Q3 2019 $114,000 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020 2020 Q3
Q2 2019 $110,000 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020 2020 Q2
Q1 2019 $98,000 +$20,000 +26% 01 Jan 2019 31 Mar 2019 10-Q 29 May 2020 2020 Q1
Q1 2018 $78,000 -$11,549 -13% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q1 2017 $89,549 -$2,242 -2.4% 01 Jan 2017 31 Mar 2017 10-Q 11 May 2018 2018 Q1
Q1 2016 $91,791 +$8,145 +9.7% 01 Jan 2016 31 Mar 2016 10-Q 12 May 2017 2017 Q1
Q1 2015 $83,646 +$21,140 +34% 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016 2016 Q1
Q1 2014 $62,506 +$3,809 +6.5% 01 Jan 2014 31 Mar 2014 10-Q 07 May 2015 2015 Q1
Q1 2013 $58,697 +$32,242 +122% 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014 2014 Q1
Q1 2012 $26,455 +$3,583 +16% 01 Jan 2012 31 Mar 2012 10-Q 14 May 2013 2013 Q1
Q1 2011 $22,872 01 Jan 2011 31 Mar 2011 10-Q 14 May 2012 2012 Q1

BIOLIFE SOLUTIONS INC Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $800,000 +$200,000 +33% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $600,000 -$100,000 -14% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 $700,000 -$100,000 -12% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
2022 $800,000 -$2,100,000 -72% 01 Jan 2022 31 Dec 2022 10-K 03 Mar 2025 2024 FY
2021 $2,900,000 +$1,500,000 +107% 01 Jan 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
2020 $1,400,000 +$856,000 +157% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2023 2022 FY
2019 $544,000 +$206,000 +61% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2022 2021 FY
2018 $338,000 -$1,000 -0.3% 01 Jan 2018 31 Dec 2018 10-K 15 May 2020 2019 FY
2017 $339,000 -$29,102 -7.9% 01 Jan 2017 31 Dec 2017 10-K 15 Mar 2019 2018 FY
2016 $368,102 +$24,884 +7.2% 01 Jan 2016 31 Dec 2016 10-K 09 Mar 2018 2017 FY
2015 $343,218 +$85,099 +33% 01 Jan 2015 31 Dec 2015 10-K 15 Mar 2017 2016 FY
2014 $258,119 +$11,047 +4.5% 01 Jan 2014 31 Dec 2014 10-K 25 Feb 2016 2015 FY
2013 $247,072 +$77,428 +46% 01 Jan 2013 31 Dec 2013 10-K 12 Mar 2015 2014 FY
2012 $169,644 +$72,529 +75% 01 Jan 2012 31 Dec 2012 10-K 12 Feb 2014 2013 FY
2011 $97,115 +$25,374 +35% 01 Jan 2011 31 Dec 2011 10-K 29 Mar 2013 2012 FY
2010 $71,741 01 Jan 2010 31 Dec 2010 10-K 29 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.